Key result
A survey of 98 pediatric cardiac intensivists showed milrinone is routinely used perioperatively by 97% of respondents following congenital heart surgery, despite a lack of compelling evidence.
Why the study?
What is the current international practice variation in the use of inotropes following congenital heart surgery?
Population
98 registered members of the Pediatric Cardiac Intensive Care Society representing 62 international centers…
Design
Cross-sectional
Authors
Loading...
Substantial international variation in postoperative inotrope use persists; leaves open the need for standardized protocols and outcome trials.
Cross-Sectional (n=98)
Yes
What is the current international practice variation in the use of inotropes following congenital heart surgery?
Despite a lack of compelling evidence, milrinone is routinely used by the vast majority of caregivers following congenital heart surgery.
Roeleveld et al. (2017) conducted a cross-sectional in Pediatric heart surgery (n=98). Inotropes was evaluated on Current international practice variation in the use of inotropes following congenital heart surgery. A survey of 98 pediatric cardiac intensivists showed milrinone is routinely used perioperatively by 97% of respondents following congenital heart surgery, despite a lack of compelling evidence.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: